DexCom Aktie
					
						
							50,70
						
						EUR
					
					
						
							-0,77
						
						EUR
					
					
						
							-1,50
						
						%
					
				
				
				
					
						
							59,85
						
						USD
					
					
						
							-8,37
						
						USD
					
					
						
							-12,27
						
						%
					
				
				
		
		
		
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                DexCom Aktie Analyse
| 02.08.18 | DexCom Buy | Canaccord Adams | |
| 03.05.18 | DexCom Buy | Canaccord Adams | |
| 23.03.18 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 28.09.17 | DexCom Outperform | Wedbush Morgan Securities Inc. | |
| 03.05.17 | DexCom Buy | Canaccord Adams | |
| 02.11.16 | DexCom Buy | Canaccord Adams | |
| 24.02.16 | DexCom Buy | The Benchmark Company | |
| 06.08.15 | DexCom Buy | Canaccord Adams | |
| 
                            
        Werbung
    
                         | |||
| 08.07.15 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 24.10.06 | DexCom Outperform | Piper Jaffray | |
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                 
                                